Fatty liver, cirrhosis double mortality risk in COVID-19

Through an international registry presented at the Digital International Liver Congress, experts found COVID-19 in the presence of liver disease like non-alcoholic fatty liver disease or cirrhosis conferred a greater risk for mortality and morbidity.“From everything that was written in the press when it comes to the pandemic, it was clear that comorbidities play a role in the outcome,” Prof. Thomas Berg, MD, head of the section of hepatology at the University Hospital in Leipzig, Germany, said during a virtual press briefing prior to the Congress. “Cardiovascular riskRead More

Share on facebook
Share on twitter
Share on linkedin